<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03062514</url>
  </required_header>
  <id_info>
    <org_study_id>PINS-026</org_study_id>
    <nct_id>NCT03062514</nct_id>
  </id_info>
  <brief_title>Trial to Evaluate the Safety and Effectiveness of Vagus Nerve Stimulation for Children With Refractory Epilepsy</brief_title>
  <official_title>Vagus Nerve Stimulation for Pediatric Intractable Epilepsy (VNS-PIE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Pins Medical Co., Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Pins Medical Co., Ltd</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Children with refractory epilepsy who are candidates for a treatment with vagus nerve
      stimulation will be prospectively randomized into 2 arms. Vagus nerve stimulation parameters
      are programmed and adjusted during outpatient clinic visits, within the normal clinical
      practice.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 9, 2017</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in seizure frequency</measure>
    <time_frame>12 weeks of stimulation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in seizure frequency</measure>
    <time_frame>6、12、24 weeks of stimulation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Engel scale description</measure>
    <time_frame>6、12、24 weeks of stimulation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in the Number of Anti-epileptic Drugs</measure>
    <time_frame>6、12、24 weeks of stimulation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GESELL mental development scales</measure>
    <time_frame>12、24 weeks of stimulation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Refractory Epilepsy</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects'Vagus Nerve stimulator is on always</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Subjects'Vagus Nerve stimulator is off from enrollment to 3 month</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PINS Vagus Nerve Stimualtor</intervention_name>
    <description>PINS Vagus Nerve Stimualtor</description>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 3-6

          2. At least 6 seizure per month

          3. Refractory Epilepsy

          4. In good health except epilepsy

          5. Patients or his(her) familyscould understand this method and sign the informed consent

          6. Patients with good compliance and could complete postoperative follow-up

        Exclusion Criteria:

          1. Results of MRI remind epilepsy caused by intracranial space-occupying lesions

          2. The vagus nerve lesion and damage

          3. Tumor, cardiopulmonary anomaly, progressive neurological diseases, asthma，mental
             disease，pepticulcer，diabetes，bad health etc, and other surgical contraindication

          4. Cann't write the epilepsy diary

          5. Participating other clinical trial

          6. Cann't complate the operation

          7. Complete the postoperative follow-up

          8. Cann't complete the promgramming
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuwu Jiang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking University First Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Liping Zou</last_name>
    <role>Study Director</role>
    <affiliation>Chinese PLA General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jianxiang Liao</last_name>
    <role>Study Director</role>
    <affiliation>Shenzhen Children's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Qian Chen</last_name>
    <role>Study Director</role>
    <affiliation>Children's hospital capital institute of pediatrics</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Baomin Li</last_name>
    <role>Study Director</role>
    <affiliation>Qilu Hospital of Shandong University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yuxing Gao</last_name>
    <role>Study Director</role>
    <affiliation>Shandong Provincial Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jianmin Liang</last_name>
    <role>Study Director</role>
    <affiliation>First Hospital of Jilin University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shaoping Huang</last_name>
    <role>Study Director</role>
    <affiliation>Second Affiliated Hospital of Xi'an Jiaotong University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fei Yin</last_name>
    <role>Study Director</role>
    <affiliation>Xiangya Hospital of Central South University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Feng Gao</last_name>
    <role>Study Director</role>
    <affiliation>The Children's Hospital, Zhejiang University School Of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yanhui Chen</last_name>
    <role>Study Director</role>
    <affiliation>Fujian Medical University Union Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>XiaoMei SHU</last_name>
    <role>Study Director</role>
    <affiliation>Zunyi Medical College</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hua Yu</last_name>
    <role>Study Director</role>
    <affiliation>Shengjing Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fumin Jia, PhD</last_name>
    <phone>010-60736388</phone>
    <email>pins_medical@163.con</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Luming Li, PhD</last_name>
    <phone>010-80699200</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Peking University First Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuwu Jiang</last_name>
      <phone>010-83573228</phone>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2017</study_first_submitted>
  <study_first_submitted_qc>February 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 23, 2017</study_first_posted>
  <last_update_submitted>December 29, 2017</last_update_submitted>
  <last_update_submitted_qc>December 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">January 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Drug Resistant Epilepsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

